The FDA plans to include aging and longevity among topics in the updated Focus Areas of Regulatory Science (FARS) report it plans to issue in federal FY 2027.

Results could provide insights into strategies for reducing anxiety symptoms in other contexts, outside of cannabis use.

Ever since artificial intelligence (AI) drug developer Xaira Therapeutics launched in April 2024 with a jaw-dropping $1 billion in committed capital and a star-studded leadership lineup—including ...

Internal benchmarks show that Ptarmigan-1 can run 5,000x faster than structure-based methods and screen over three billion compounds in a day.

Most screening readouts are snapshots. An endpoint measurement can obscure differences in association rate and dissociation ...

Consortium members are expected to have access to the dataset by early 2027, and there are plans to add more complex antibody ...

Merck acquires global rights to SciBrunch Therapeutics’ SPR2015, a preclinical oral KRAS G12D inhibitor, in a deal worth up ...

Nektar Therapeutics won its legal dispute with Eli Lilly over rezpegaldesleukin, but the court victory failed to deliver a ...

Researchers at Washington University School of Medicine in St. Louis have developed a potential antibody-based approach to ...

The findings by scientists at NYU Abu Dhabi provide new insight into how cells respond when cancer-causing genes are ...

Mayo Clinic researchers have discovered that adults aged 50 years or younger with colorectal and breast cancers have distinct gut microbiome patterns compared with individuals diagnosed later in life.

Researchers at the Nano Life Science Institute at Kanazawa University in Japan say they have directly visualized how enzymes ...